(Washington, DC – December 5, 2014) – Galileo Analytics co-founder Anna McCollister-Slipp will give testimony today before a meeting of the Office of the National Coordinator for Health IT’s Policy Committee’s Privacy and Security Workgroup.

McCollister-Slipp will join a roster of experts on various aspects of big health data. the agenda covers topics ranging from the potential benefits and opportunities of health data to create a learning health system to methods for ensuring patient privacy and security.  McCollister-Slipp will address the workgroup at 2:30 pm EST, providing a patient perspective on concerns about the use of big data in health care.

  • Other speakers during the day include:
  • Rich Platt, Harvard Pilgrim healthcare Institute
  • Steve Downs, Robert Wood Johnson Foundation
  • Patti Brennan, University of Wisconsin-Madison College of Engineering
  • Michele DeMooy, Center for Democracy and Technology
  • Mark Savage, Ntional Partnership for Women and Families
  • Khaled El Emam, University of Ottawa
  • Bob Gellman, private consultant
  • Fred Cate, Indiana University Maurer School of Law
  • Deven McGraw, Chair, Manatt, Phelps & Phillips, LLP
  • Stanley Crosley, Co-Chair, Drinker Biddle & Reath LLP

For more information about today’s meeting and to join the meeting virtually, visit:




About Admin

Anna McCollister-Slipp is co-founder of Galileo Analytics, a Visual Data Exploration and advanced data analytics company focused on democratizing access to and understanding of complex health data. In addition, she is the Chief Advocate for Participatory Research at the Scripps Translational Science Institute, where she is charged with bringing the expertise of patients, caregivers and community physicians into the design of health research. Anna’s passion for innovation in health data research is rooted in her personal experiences living with type 1 diabetes. As an entrepreneur and advocate, she speaks frequently about the promise of digital health, the imperative for patient data access and the need for improved outcomes measures for chronic disease. Anna serves on a number of government and private committees and boards aimed at promoting innovative ways to better understand, manage and treat complex health conditions, such as diabetes.

%d bloggers like this: